
The Canopy Growth community is heavily focused on the DEA rescheduling hearing's conclusion and its implications for Schedule III, while also reacting to the sector's M&A wave sparked by Curaleaf's takeover bid for Aurora Cannabis, CGC's recent earnings beat with improved margins, and ongoing fears of a reverse split, with bulls and bears sharply divided over the stock's path forward.